Antiangiogenic therapies for high-grade glioma

被引:0
|
作者
Andrew D. Norden
Jan Drappatz
Patrick Y. Wen
机构
[1] Brigham and Women's Hospital and Center for Neuro-Oncology,Division of Neuro
[2] Dana-Farber/Brigham and Women's Cancer Center,Oncology, Department of Neurology, Department of Medical Oncology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
High-grade gliomas are highly vascularized tumors that represent attractive targets for antiangiogenic therapies. In this article, Norden et al. discuss the rationale for targeting angiogenesis in high-grade gliomas and review the published clinical trial evidence, focusing primarily on therapies that target vascular endothelial growth factor and its receptors.
引用
收藏
页码:610 / 620
页数:10
相关论文
共 50 条
  • [1] Antiangiogenic therapies for high-grade glioma
    Norden, Andrew D.
    Drappatz, Jan
    Wen, Patrick Y.
    NATURE REVIEWS NEUROLOGY, 2009, 5 (11) : 610 - 620
  • [2] Antiangiogenic therapy for high-grade glioma
    Khasraw, Mustafa
    Ameratunga, Malaka S.
    Grant, Robin
    Wheeler, Helen
    Pavlakis, Nick
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [3] Combined gene therapies for high-grade glioma
    Bernstock, Joshua D.
    Ling, Alexander
    Chiocca, E. Antonio
    LANCET ONCOLOGY, 2023, 24 (09): : 949 - 950
  • [4] Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients
    Hutterer, Markus
    Hattingen, Elke
    Palm, Christoph
    Proescholdt, Martin Andreas
    Hau, Peter
    NEURO-ONCOLOGY, 2015, 17 (06) : 784 - 800
  • [5] CHANGE IN PATTERN OF RELAPSE AFTER ANTIANGIOGENIC THERAPY IN HIGH-GRADE GLIOMA
    Narayana, Ashwatha
    Kunnakkat, Saroj D.
    Medabalmi, Praveen
    Golfinos, John
    Parker, Erik
    Knopp, Edmond
    Zagzag, David
    Eagan, Patricia
    Gruber, Deborah
    Gruber, Michael L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 77 - 82
  • [6] Novel chemotherapeutics and other therapies for treating high-grade glioma
    Kang, Jennifer H.
    Adamson, Cory
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (10) : 1361 - 1379
  • [7] Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma
    Rallis, Kathrine S.
    George, Alan Mathew
    Wozniak, Anna Maria
    Bigogno, Carola Maria
    Chow, Barbara
    Hanrahan, John Gerrard
    Sideris, Michail
    CANCER GENOMICS & PROTEOMICS, 2022, 19 (04) : 390 - 414
  • [8] Antiangiogenic Therapy for High-Grade Gliomas
    Chamberlain, Marc C.
    Raizer, Jeff
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (03) : 184 - 194
  • [9] Recurrent High-Grade Glioma
    Eudocia C. Quant
    Jan Drappatz
    Patrick Y. Wen
    Andrew D. Norden
    Current Treatment Options in Neurology, 2010, 12 : 321 - 333
  • [10] Pseudoprogression in high-grade glioma
    Knudsen-Baas, K. M.
    Moen, G.
    Fluge, O.
    Storstein, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 : 31 - 37